Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of chlorine guanabenz derivatives for treating polyglutamine expansion associated diseases

Use of chlorine guanabenz derivatives for treating polyglutamine expansion associated diseases

US Patent 7932422 · Granted Apr 26, 2011

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Hydrazone derivatives for preventing or treating EBV-related cancers2022
Methods for selecting phosphatase selective and non-selective phosphatase inhibi2022
Inhibitors and their uses2022
Inhibitors and their uses2022
Inhibitors and their uses2021
Benzylideneguanidine derivatives and therapeutic use for the treatment of protei2021
Benzylideneguanidine derivatives and therapeutic use for the treatment of protei2020
Benzylideneguanidine derivatives and therapeutic use for the treatment of protei2018
Benzylideneguanidine derivatives and therapeutic use for the treatment of protei2017
Use of guanabenz and its derivatives for making drugs for treating cystic fibros2012
Screening molecules with anti-prion activity: kits, methods and screened molecul2012